Chemotherapy/ICI Combos Falter as Second-Line Treatment for Gastric Cancer
(MedPage Today) -- Combining chemotherapy with one or two immune checkpoint inhibitors (ICIs) as second-line treatment for advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma failed to improve progression-free survival (PFS) at 4...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology